Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization

This publication has 9 references indexed in Scilit:

• Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study
  The Lancet, 2002
• Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization
  New England Journal of Medicine, 2001
• A direct comparison of tirofiban and abciximab during percutaneous coronary revascularization and stent placement: Rationale and design of the TARGET study
  American Heart Journal, 2000
• Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease
  The American Journal of Cardiology, 2000
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Decreased Ankle/Arm Blood Pressure Index and Mortality in Elderly Women
  JAMA, 1993
• The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women
  Atherosclerosis, 1993
• Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
  New England Journal of Medicine, 1992
• The prevalence of peripheral arterial disease in a defined population.
  Circulation, 1985